Clinical Trials Browser

Interventional × parsaclisib × Breast × Clear all

NCT02646748 2022-03-31

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT04142554 2020-11-03

LCCC1820

Phase 1 Withdrawn

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms